Boxer Capital, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,514,520
+43668.5%
1,094,0000.0%1.20%
-49.7%
Q2 2023$51,440
+12.1%
1,094,0000.0%2.39%
+5.8%
Q1 2023$45,904
-99.9%
1,094,0000.0%2.26%
+2.5%
Q4 2022$41,725,160
-2.6%
1,094,0000.0%2.20%
-8.7%
Q3 2022$42,841,000
+21.2%
1,094,0000.0%2.41%
+7.6%
Q2 2022$35,336,000
-2.4%
1,094,0000.0%2.24%
+20.3%
Q1 2022$36,211,000
-22.2%
1,094,0000.0%1.86%
+2.9%
Q4 2021$46,539,000
-4.0%
1,094,0000.0%1.81%
+6.8%
Q3 2021$48,475,000
-22.0%
1,094,0000.0%1.69%
-22.8%
Q2 2021$62,150,000
-24.1%
1,094,0000.0%2.19%
-21.0%
Q1 2021$81,886,000
-13.5%
1,094,0000.0%2.78%
-8.7%
Q4 2020$94,642,000
+41.5%
1,094,0000.0%3.04%
+31.6%
Q3 2020$66,865,000
+47.0%
1,094,0000.0%2.31%
+15.6%
Q2 2020$45,489,000
+3.4%
1,094,000
-28.6%
2.00%
-33.3%
Q1 2020$44,014,000
+74.2%
1,532,510
+337.9%
3.00%
+109.9%
Q4 2019$25,267,000350,0001.43%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Sio Capital Management, LLC 179,200$29,516,00016.65%
TRV GP II, LLC 547,916$90,247,00016.25%
Opus Point Partners Management, LLC 71,000$11,694,00010.12%
Casdin Capital, LLC 250,000$41,178,00010.03%
RA Capital Management 455,173$74,972,0006.27%
Crawford Lake Capital Management, LLC 154,278$25,411,0006.00%
Palo Alto Investors LP 810,806$133,548,0005.75%
GREAT POINT PARTNERS LLC 200,000$32,942,0005.62%
BB BIOTECH AG 1,042,439$171,700,0004.84%
Crawford Lake Capital Management, LLC 92,300$15,203,0003.59%
View complete list of SAGE THERAPEUTICS INC shareholders